Made O'Meter
Découvrez d'où provient une marque ou un produit
Trosyd is a well-established medicated antifungal brand widely used to treat fungal nail infections (onychomycosis) and skin mycoses, containing the active substance tioconazole. The brand was originally researched and developed by the American multinational pharmaceutical corporation Pfizer in the late 1970s and early 1980s.
Over the years, rights to the brand across various European markets changed hands. In Northern Europe and Scandinavia, marketing and commercial distribution were handled through companies such as Galenica and Meda. Following international corporate consolidation, Meda was acquired by Mylan, which subsequently merged with Upjohn (a former Pfizer division) to form Viatris Inc., headquartered in the United States. In certain other markets, rights to the Trosyd brand name are held or marketed by regional pharmaceutical companies such as Giuliani in Italy.
For the Swedish and wider European consumer pharmacy market, Trosyd nail lacquer solution is typically manufactured in pharmaceutical facilities in Italy. Today, Viatris remains the ultimate corporate parent overseeing the distribution and commercial rights of the Trosyd formulation in Sweden.
Signaler un bug ou donner votre avis
Made O'Meter utilise une analyse alimentée par l'IA pour estimer les origines de production. Les résultats ne sont pas toujours précis à 100%.
2025 i7even ApS Copenhague Danemark - Tous droits réservés. Les concepts et méthodes utilisés dans cette application ne peuvent être reproduits sans autorisation